Akums
Live Price
Recent news and updates for AKUMS will appear here soon.
"Robust technical setup for AKUMS with strong AI conviction. The bullish trend in the healthcare space is accelerating while RSI at 56 suggests there is still significant room for upside before reaching overbought territory."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offers branded formulations on various dosage forms, including tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form-fill-seal products, topical preparations, eye drops, dry powder injections, and gummies for therapeutic areas, such as antiinfectives, pain management, gastroenterology, orthopaedics, cardio-diabetic care, critical care, respiratory, and gynaecology. In addition, the company operates as pharmaceutical contract development and manufacturing company. Akums Drugs and Pharmaceuticals Limited was incorporated in 2004 and is based in Delhi, India.
As of the latest market session, Akums (AKUMS) is trading at ₹766.7, representing a move of -0.69% from the previous close.
Akums is listed and traded under the ticker symbol AKUMS on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Akums's stock price moved by -0.69%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 90% bullish probability for AKUMS stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Akums shares reached a high of ₹796.55 and hit a low of ₹409.3.
AKUMS exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 2,16,010 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Akums has a market capitalization of ₹11738.34 Cr, designating its size class inside the Healthcare sector.
Akums has a current dividend yield of 13.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Akums's trailing Price-to-Earnings (P/E) ratio is 40.20. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Akums (AKUMS) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Akums's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore AKUMS's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for AKUMS are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Akums operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.